DR. TERRY PLASSE, MD
Osteopathic Medicine at York Ave, New York, NY
License number
New York 120601-1
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
1725 York Ave, New York, NY 10128
Phone
(212) 860-8368
Personal information
See more information about TERRY PLASSE at radaris.comName
Address
Phone
1725 York Ave, New York, NY 10128
Organization information
See more information about TERRY PLASSE at bizstanding.comTerry Plasse MD
1725 York Ave, New York, NY 10128
Industry:
Internist
Phone:
(212) 860-8368 (Phone)
Terry Freeman Plasse
Professional information
Terry F Plasse, New York NY
Specialties:
Internist
Address:
1725 York Ave, New York, NY 10128
Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection
US Patent:
2007008, Apr 19, 2007
Filed:
Oct 2, 2006
Appl. No.:
11/537914
Inventors:
Terry Plasse - New York NY, US
International Classification:
A61K 31/353
US Classification:
514454000
Abstract:
Patients with symptomatic HIV infection, including AIDS and ARC are treated to increase appetite and to cause a reduction in loss of weight. The delta-9-tetrahydrocannabinol may be administered orally, in capsules, or in tablets, or by injection, suppository, intranasal, transdermal, inhalant or sublingual administration.
Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection
US Patent:
2004020, Oct 21, 2004
Filed:
Dec 12, 2003
Appl. No.:
10/735017
Inventors:
Terry Plasse - New York NY, US
International Classification:
A61K031/353
US Classification:
514/454000
Abstract:
Patients with symptomatic HIV infection, including AIDS and ARC are treated to increase appetite and to cause a reduction in loss of weight. The delta-9-tetrahydrocannabinol may be administered orally, in capsules, or in tablets, or by injection, suppository, intranasal, transdermal, inhalant or sublingual administration.
Appetite Stimulation And Reduction Of Weight Loss In Patients Suffering From Symptomatic Hiv Infection
US Patent:
2003010, May 29, 2003
Filed:
Jun 3, 1992
Appl. No.:
07/893554
Inventors:
TERRY F. PLASSE - NEW YORK NY, US
International Classification:
A61K031/335, A61K031/35
US Classification:
514/454000
Abstract:
Patients with symptomatic HIV infection, including AIDS and ARC are treated to increase appetite and to cause a reduction in loss of weight. The delta-9-tetrahydrocannabinol may be administered orally, in capsules, or in tablets, or by injection, suppository, intranasal, transdermal, inhalant or sublingual administration.